Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2016
Number of items: 2.

2022

Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Pomej, Katharina ORCID: 0000-0002-2807-3565, Kirstein, Martha M., Hucke, Florian ORCID: 0000-0001-7887-3440, Finkelmeier, Fabian, Waidmann, Oliver, Himmelsbach, Vera, Schulze, Kornelius, von Felden, Johann ORCID: 0000-0003-2839-5174, Frundt, Thorben W., Stadler, Marc, Heinzl, Harald, Shmanko, Kateryna, Spahn, Stephan, Radu, Pompilia, Siebenhuener, Alexander R., Mertens, Joachim C., Rahbari, Nuh N., Kuetting, Fabian, Waldschmidt, Dirk-Thomas, Ebert, Matthias P., Teufel, Andreas, De Dosso, Sara, Pinato, David J., Pressiani, Tiziana ORCID: 0000-0001-6919-1536, Meischl, Tobias, Balcar, Lorenz ORCID: 0000-0002-6708-3061, Mueller, Christian, Mandorfer, Mattias, Reiberger, Thomas ORCID: 0000-0002-4590-3583, Trauner, Michael ORCID: 0000-0002-1275-6425, Personeni, Nicola ORCID: 0000-0002-7995-272X, Rimassa, Lorenza ORCID: 0000-0001-9957-3615, Bitzer, Michael ORCID: 0000-0002-4463-8263, Trojan, Joerg, Weinmann, Arndt, Wege, Henning, Dufour, Jean-Francois, Peck-Radosavljevic, Markus, Vogel, Arndt and Pinter, Matthias (2022). Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. J. Hepatol., 76 (2). S. 353 - 365. AMSTERDAM: ELSEVIER. ISSN 1600-0641

2016

Scholz, Alexander, Harter, Patrick N. ORCID: 0000-0001-5530-6910, Cremer, Sebastian, Yalcin, Burak H., Gurnik, Stefanie, Yamaji, Maiko, Di Tacchio, Mariangela, Sommer, Kathleen, Baumgarten, Peter, Baehr, Oliver, Steinbach, Joachim P., Trojan, Joerg, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Braun, Christian, Schittenhelm, Jens, Frueh, Jochen T., Ullrich, Evelyn ORCID: 0000-0001-8530-1192, Mittelbronn, Michel, Plate, Karl H. and Reiss, Yvonne (2016). Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol. Med., 8 (1). S. 39 - 58. HOBOKEN: WILEY-BLACKWELL. ISSN 1757-4684

This list was generated on Wed May 1 04:27:13 2024 CEST.